Mereo BioPharma Group plc (MREO)
↓ Download CSV- Sector Manufacturing
- Incorporated X0
- Fiscal year ends Dec 31
In fiscal 2025, Mereo BioPharma Group plc reported revenue of $500.0K. The company ran a net loss, with a net margin of -8375.6%. It held $45.92M in total assets against $5.00M in total liabilities.
Key ratios (FY2025)
-8021.4%
Operating margin
-8375.6%
Net margin
-102.4%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $500.0K | $0 | $10.00M | $0 | — |
| Operating Income | -$40.11M | -$47.36M | -$28.42M | -$54.43M | — |
| Net Income | -$41.88M | -$43.25M | -$29.47M | -$42.22M | — |
| EPS (Diluted) | $-0.05 | $-0.06 | $-0.04 | $-0.07 | — |
| Total Assets | $45.92M | $76.39M | $66.50M | $77.41M | — |
| Total Liabilities | $5.00M | $15.42M | $15.96M | $26.01M | — |
| Shareholders' Equity | $40.92M | $60.97M | $50.54M | $51.40M | $92.20M |
| Cash & Equivalents | $40.99M | $69.80M | $57.42M | $68.18M | — |
| Operating Cash Flow | -$30.97M | -$32.83M | -$21.13M | -$48.82M | — |
| Capital Expenditures | $20.0K | $0 | $0 | $13.0K | — |
| Shares Outstanding | 797.12M | 739.62M | 659.45M | 603.20M | — |